ClinConnect ClinConnect Logo
Search / Trial NCT06293924

Pericardial Fluid Analysis in Recurrent Pericarditis

Launched by ASST FATEBENEFRATELLI SACCO · Mar 2, 2024

Trial Information

Current as of July 12, 2025

Enrolling by invitation

Keywords

Acute Pericarditis Recurrent Pericarditis Pericardial Effusion Pericardiocentesis Cardiac Surgery Cytofluorometry Gene Expression Analysis Autoinflammatory Disorders

ClinConnect Summary

Idiopathic recurrent pericarditis is a condition characterized by recurrent inflammation of the pericardial sac and sometimes another serosa, accompanied by systemic signs and symptoms. Differential diagnosis of this condition includes all forms of pericarditis secondary to other diseases such as infections, autoimmune and autoinflammatory diseases, malignancy and other conditions (post-actinic, post-traumatic, post-pericardiotomy or post-infarct pericarditis, or those associated with metabolic dysregulations such as uremia). Some patients have pericardial effusion without any signs of infl...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with acute idiopathic or post-cardiac injury pericarditis who require diagnostic or therapeutic pericardiocentesis (Interventional arm)
  • Subjects with non-inflammatory pericardial effusion who require diagnostic or therapeutic pericardiocentesis (First control arm)
  • Patients who undergo cardiac surgery that involves a pericardiotomy (Second control arm)
  • Exclusion Criteria:
  • Pregnancy or breastfeeding
  • Ongoing infections, including active viral hepatitis or Coronavirus Disease 19 (COVID-19) positivity in the previous 21 days
  • Systemic inflammatory disorders not attributable to pericarditis, excluding inflammatory diseases in remission
  • Solid or haematological malignancies, ongoing or less than 6 months disease-free interval or anti-blastic chemotherapy (excluding the hormone therapy)
  • Immunosuppressive therapy for reasons other than pericarditis treatment.
  • Moderate-severe kidney failure (GFR \< 30 ml/min)
  • Moderate-severe liver failure (Child-Pug B or C), active hepatitis
  • Diabetes mellitus
  • Severe hypoproteinemia/malnutrition

About Asst Fatebenefratelli Sacco

Asst Fatebenefratelli Sacco is a prominent healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong commitment to ethical standards and patient safety, the organization collaborates with leading researchers and healthcare professionals to explore new therapies and treatment options across various medical fields. Asst Fatebenefratelli Sacco leverages its extensive expertise and state-of-the-art facilities to contribute to the global body of medical knowledge, ultimately aiming to enhance the quality of care for patients both locally and beyond.

Locations

Milan, Lombardia, Italy

Patients applied

0 patients applied

Trial Officials

Antonio Luca Brucato, Prof.

Principal Investigator

ASST Fatebenefratelli Sacco

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported